The Current and Future Management of Acute Heart Failure Syndromes

Peter S. Pang; Michel Komajda; Mihai Gheorghiade


Eur Heart J. 2010;31(7):777-783. 

In This Article


Improving post-discharge outcomes for patients with AHFS is a fundamental goal of therapy. Current management remains challenging, as the evidence for initial management is limited. A better understanding of existing therapies is needed. In addition, certain healthcare systems and institutions have better outcomes despite a similar therapeutic armamentarium, suggesting the benefits of optimization of therapies, including psychosocial and socioeconomic considerations. Better measures of HF quality are needed.

In spite of the commonly held belief that the high mortality and morbidity seen post-discharge is inevitable, we believe future management holds great promise as many conditions that contribute to progression of HF can be effectively treated (e.g. CAD, valvular disease, ventricular dyssynchrony). In addition, since progression of LV dysfunction contributes to the poor prognosis of HF, identifying patients with viable but dysfunctional myocardium, which is potentially salvageable, and for whom future therapies can be identified, may be the last frontier in the treatment of AHFS.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: